In Depth Observational Clinical Trial Of Retinitis Pigmentosa Patients

Launched by POWER LIFE SCIENCES INC. · Apr 28, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how different groups of people with retinitis pigmentosa—a condition that causes vision loss—participate in research studies. The goal is to gather information that can help future patients by identifying trends in participation across various demographic groups. This trial is not yet recruiting participants, but when it begins, it will include adults aged 18 and older who have been confirmed to have retinitis pigmentosa.

To be eligible, participants must be able to provide written consent and should not be currently involved in another study that is testing a treatment. Additionally, women who could become pregnant must have a negative pregnancy test and cannot be breastfeeding. If you participate, you can expect to share your experiences and possibly help improve the understanding of retinitis pigmentosa for future patients. Your feedback will be valuable in shaping how research is conducted moving forward.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Is 18+ years old
• • Confirmed diagnosis of retinitis pigmentosa
• • Signed Written Informed Consent
• Exclusion Criteria:
• • Inability to perform regular electronic reporting
• • Participant is actively receiving study therapy in another trial
• • Women of childbearing potential without a negative pregnancy test; or women who are lactating.